Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

ConditionTuberous Sclerosis Complex (TSC)

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age2-65

SponsorOils4Cure

About this trial

1\. To assess treatment efficacy with YCJ-01 by changes in the number of epileptic seizures in patients with refractory epilepsy secondary to Tuberous Sclerosis Complex. 2. To assess the safety of the treatment with YCJ-01 in patients with refractory epilepsy secondary to Tuberous Sclerosis Complex.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

YCJ-01 Full Spectrum cannbis Extract
Placebo

Treatment groups

84 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Oils4Cure

Lead sponsor

Source ClinicalTrials.gov